Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).

Naohiro OkanoChigusa MorizaneShogo NomuraHideaki TakahashiHidetaka TsumuraHironaga SatakeNobumasa MizunoKunihiro TsujiKazuhiko ShiojiAkinori AsagiKohichiroh YasuiSho KitagawaTomomi KashiwadaAtsushi IshiguroMasashi KanaiMakoto UenoTakashi OguraSatoshi ShimizuKazutoshi TobimatsuMasayo MotoyaKoji NakashimaMasafumi IkedaTakuji OkusakaJunji Furuse

Published in: International journal of clinical oncology (2020)

UMIN000017894.

Keyphrases

prostate cancer
phase ii
clinical trial
open label
radical prostatectomy
phase iii
double blind
placebo controlled
squamous cell carcinoma
locally advanced